Letter and Correspondence
Crescentic glomerulonephritis during treatment with interferon-α2b
Jean Marc Durand,
Jean Marc Durand
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Frederique Retornaz,
Frederique Retornaz
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Elodie Cretel,
Elodie Cretel
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Gilles Kaplanski,
Gilles Kaplanski
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Jacques Soubeyrand,
Jacques Soubeyrand
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author
Jean Marc Durand,
Jean Marc Durand
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Frederique Retornaz,
Frederique Retornaz
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Elodie Cretel,
Elodie Cretel
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Gilles Kaplanski,
Gilles Kaplanski
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author Jacques Soubeyrand,
Jacques Soubeyrand
Department of Internal Medicine, CHU Sainte-Marguerite, Marseille, France
Search for more papers by this author
First published: February 1995
No abstract is available for this article.
References
- 1
Quesada JR,
Talpaz M,
Rios A,
Kurzrock R,
Gutterman JU:
Clinical toxicity of interferons in cancer patients: a review.
J Clin Oncol
234–243,
1986.
- 2
Conkon KC,
Urba WJ,
Smith JW, et al:
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy.
Cancer
65:
2237,
1990.
- 3
Averbuch SD,
Austin HA,
Sherwin SA, et al:
Acute interstitial nephritis with the nephrotic syndrome following recombinant leucocyte A interferon therapy for mycosis fungoides.
N Engl J Med
310:
32–35,
1984.
- 4
Selby P,
Kohn J,
Raymond J, et al:
Nephrotic syndrome during treatment with interferon.
BMJ
290:
1180,
1985.
- 5
Lederer E,
Truong L.
Unusual glomerular lesion in a patient receiving long-term interferon alpha.
Am J Kidney Dis
5:
316–318,
1992.
- 6
Sawamura M,
Matsushima T,
Tamura J,
Murakami H,
Tsuchiya J:
Renal toxicity in long-term alpha Interferon treatment in a patient with myeloma.
Am J Hematol
41:
146,
1992
- 7
Noël C,
Vrtovsnik F,
Facon T,
Noël-Waller MP,
Hazzan M,
Jouet JP,
Bauters F,
Lelièvre G.
Acute and definitive renal failure in progressive multiple myeloma treated with interferon recombinant alpha-2a: Report on two patients.
Am J Hematol
41:
298–299,
1992.
- 8
Gresser I,
Maury C,
Tovey M:
Progressive glomerulonephritis in mice treated with interferon preparation at birth.
Nature
263:
420–422,
1976.
